Refractory Epilepsy Terminated Phase 2 Trials for Diazepam (DB00829)

IndicationStatusPhase
DBCOND0032649 (Refractory Epilepsy)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02474407Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)Treatment